Cobb Stuart 4
4 · Neurogene Inc. · Filed May 15, 2025
Insider Transaction Report
Form 4
Neurogene Inc.NGNE
Cobb Stuart
Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-05-14$15.15/sh−6,797$103,003→ 20,794 total
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on February 6, 2025.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.78 to $15.75. The reporting person undertakes to provide Neurogene Inc. (the "Company"), any securityholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.